Drug intelligence / Profile preview

coumestrol

Development stage
Preclinical
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Subcutaneous
01

Overview

Coumestrol is a naturally occurring phytoestrogen belonging to the class of coumestans, polycyclic aromatic compounds derived from pterocarpan oxidation[3][2]. It is found in various plants including alfalfa, clover, legumes, soybeans, green beans, miso, and fruits[3][2]. Coumestrol mimics estrogen by binding to estrogen receptors ERα and ERβ, with a notably higher affinity for ERβ[3][5]. Its estrogenic potency is 30–100 times greater than that of typical isoflavones, but much less than estradiol[3]. Coumestrol acts as a competitive agonist at estrogen receptors, regulating metabolic, bone, and neuroprotective functions, and it can be used as a substitute for hormone therapy in conditions like menopause[3][5]. Mechanistically, it also inhibits aromatase and 3α-hydroxysteroid dehydrogenase, affecting steroid hormone biosynthesis[3]. Additional activities include selective and competitive inhibition of monoamine oxidase A (MAO-A) and inhibition of amyloid-beta (Aβ) aggregation, potentially useful in treating depression and Alzheimer's disease[1]. Coumestrol reversibly inhibits casein kinase II (CK2) as an ATP-competitive inhibitor[6]. It shows estrogen-mimetic effects on metabolic regulation, reducing fat accumulation and promoting bone mineralization[5]. Its metabolic and neuroprotective effects are primarily mediated via ERβ agonism[5]. Coumestrol exhibits mutagenic and clastogenic properties at high concentrations[3].

Other names
coumestrol3,9-Dihydroxy-6H-[1]benzofuro[3,2-c]chromen-6-one3,9-Dihydroxy-6H-benzofuro(3,2-c)(1)benzopyran-6-one
02

Targets

Aβ (Amyloid-beta peptides and aggregates)ESR2 (ERβ)MAOA (Monoamine oxidase A)ESR1 (ERα)

Beyond the preview

Go deeper on coumestrol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on coumestrol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call